Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study
| Image |  |
|---|---|
| Description | scientific article published on 13 September 2016 |
| Author/s |
author: Stephan Stilgenbauer Susan O'Brien Michael Hallek Timothy G. Call Michael J. Keating Peter Hillmen |
| Publication date | September 13, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |